Fundraising Fox
/Companies
Sign in

Audentes Therapeutics

San Francisco, US · Founded 2012 · Delaware corporation · 7 known investors

Find your way into Audentes Therapeutics

406 people in our graph share verified history with the Audentes Therapeutics team — schools, employers, funds. One of them is your warm intro.

Megan Blewettunlockedknows Matthew R. Patterson · together at IRIS MEDICINE (overlapped)
knows the team · via Vor Biopharma
×2knows the team · via Alliance for Regenerative Medicine
×8knows the team · via Audentes Therapeutics
Biotech

Founders & leadership

Audentes Therapeutics was founded in 2012 by Matthew Patterson.

MPMatthew Patterson
Matthew PattersonFounder · Strategic Advisor2020–2021Venture Partner - US Investments at SR One Capital Management

Board

JSJonathan Silverstein
Jonathan SilversteinBoard directorPartner at OrbiMed
SSSteve Squinto
Steve SquintoBoard directorVenture Partner at OrbiMed
KPKush Parmar
Kush ParmarBoard Of DirectorsManaging Partner at 5AM Ventures
JLJonathan Leff
Jonathan LeffBoard directorPartner at Deerfield Management Company
TW
Thomas WoiwodeBoard director
LGLouis G. Lange
Louis G. LangeBoard directorPartner at Asset Management Company
TS
Thomas SchuetzBoard director

Investors · 7

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

venBio Partnerslisted by venBio PartnersSan Francisco

How we know: venBio Partners's portfolio page · Not right? Tell us

5AM VenturesreportedSan Francisco · $100K – $4M

How we know: a partner's Signal profile · Not right? Tell us

Deerfield Management CompanyreportedNew Yorkvia Jonathan Leff · board

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

OrbiMedinferredNew York · $1M – $75Mvia Jonathan Silverstein · board

How we know: board seat on SEC Form D · Not right? Tell us

VenrockreportedPalo Alto · $500K – $10M

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$107.5M disclosed across 2 of 3 rounds · 2014–2015

▶$65MraisedOct 2015 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve SquintoDirector
  • Matthew PattersonExecutive Officer, Director
  • Jonathan LeffDirector
  • Kush ParmarDirector
  • Thomas WoiwodeDirector
  • Jonathan SilversteinDirector
  • Thomas SchuetzDirector
  • Louis LangeDirector
Offering amount
$65M
Amount sold
$65M
First sale
Oct 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedSep 2015 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan SilversteinDirector
  • Steve SquintoDirector
  • Kush ParmarDirector
  • Jonathan LeffDirector
  • Matthew PattersonExecutive Officer, Director
  • Thomas WoiwodeDirector
  • Louis G. LangeDirector
  • Thomas SchuetzDirector
First sale
Aug 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$42.5MraisedDec 2014 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas SchuetzDirector
  • Kush ParmarDirector
  • Matthew PattersonExecutive Officer, Director
  • Jonathan SIlversteinDirector
  • Thomas WoiwodeDirector
  • Jonathan LeffDirector
Offering amount
$42.5M
Amount sold
$42.5M
First sale
Nov 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

The Audentes Therapeutics mafia →

6 people who came through Audentes Therapeutics went on to found or lead other companies.

Matthew R. PattersonExecutive Officer, DirectorFounded IRIS MEDICINE +1Genine WinslowDirector Research AnalyticsFounded Chameleon Biosciences +1Kush M ParmarDirectorFounded Homology MedicinesLou LangeDirectorFounded CV TherapeuticsGraeme FielderAssociate - Corporate Development & Commercial PlanningFounded ChiasmaSchuetz ThomasBoard of DirectorsFounded Compass Therapeutics

Frequently asked questions

Who founded Audentes Therapeutics?
Audentes Therapeutics was founded by Matthew Patterson in 2012.
Who are Audentes Therapeutics's investors?
Audentes Therapeutics's investors include Asset Management Company, RA Capital, venBio Partners, 5AM Ventures, Deerfield Management Company, OrbiMed, Venrock.
How much funding has Audentes Therapeutics raised?
Audentes Therapeutics has disclosed $107.5M raised across 2 of its 3 known rounds.
Where is Audentes Therapeutics headquartered?
Audentes Therapeutics is headquartered in San Francisco, US.